Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Electroacupuncture at ST36 to see if it lowers postoperative inflammation after heart surgery with bypass

Official title: Effect of Electroacupuncture at Bilateral Zusanli (ST36) on Postoperative Inflammatory Response and Organ Injury in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass: A Prospective, Randomized, Parallel-Controlled Trial

Run by Sir Run Run Shaw Hospital · NCT07795112 · Data updated 2026-11-12

This trial tests whether bilateral ST36 electroacupuncture given after cardiac surgery with bypass can reduce inflammation and improve recovery compared with a sham procedure.

More Systemic Inflammatory Response Syndrome trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment140 (estimated)
SponsorSir Run Run Shaw Hospital
Academic / other
Drugs / interventionsprednisone
Locations1 site (Hangzhou, Zhejiang)
StatusRecruiting
StartedSeptember 1, 2026
Main results expectedFebruary 1, 2027
Study endsMay 1, 2027
Registry record updatedSeptember 8, 2026
Trial IDNCT07795112 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) scheduled for elective cardiac surgery with cardiopulmonary bypass who can consent.

Probably not a fit

Patients for whom inflammation is not driven by neuroimmune pathways or who do not respond to this intervention may see no benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized, parallel-group trial enrolling adults undergoing elective cardiac surgery with cardiopulmonary bypass. Participants are assigned after surgery to receive either bilateral ST36 electroacupuncture or a control procedure without electrical stimulation at the same acupoint, each session lasting 30 minutes and repeated twice. All participants receive standard postoperative care, and the primary outcomes include C-reactive protein levels and organ dysfunction scores on postoperative day 2. Secondary outcomes cover vasoactive drug use, inflammatory markers, mechanical ventilation, ICU/hospital length of stay, and other clinical indicators. The study aims to determine if electroacupuncture can modulate the systemic inflammatory response related to CPB and surgical trauma.

Why it matters

Potential benefit: If successful, this approach could reduce postoperative inflammation and potentially shorten recovery after cardiac surgery.

How similar studies have gone: Previous preclinical work suggests a potential anti-inflammatory effect of ST36 electroacupuncture, but clinical evidence in this setting is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥18 years.
* Scheduled to undergo elective cardiac surgery with cardiopulmonary bypass (CPB) support.
* The surgical procedure may include coronary artery bypass grafting (CABG), valve replacement, valve repair, or another cardiac surgical procedure performed with CPB support.
* Voluntarily agrees to participate in the study and provides written informed consent. If a participant is unable to read and sign the informed consent form because of incapacity or another reason, the informed consent process will be conducted with the participant's legally authorized representative, who will sign on the participant's behalf. If a participant is unable to read the informed consent form, the informed consent process will be witnessed by an independent witness, who will sign the informed consent form.

Exclusion Criteria:

* Membership in a vulnerable population other than older adults or individuals who are illiterate, including patients with psychiatric disorders, cognitive impairment, critical illness, or another vulnerable condition.
* Pregnant or breastfeeding.
* Local skin or soft-tissue infection, erysipelas, or another condition at the acupuncture site that makes acupuncture treatment unsuitable.
* History of organ transplantation.
* Active malignancy.
* Long-term high-dose corticosteroid therapy before surgery, defined as prednisone ≥20 mg/day for ≥14 days or a cumulative prednisone-equivalent dose \>700 mg.
* Severe chronic organ dysfunction before surgery, including any of the following:
* Chronic respiratory disease with a baseline PaO₂/FiO₂ ratio \<300.
* Hematological disease, such as leukemia, lymphoma, or myeloma, or a baseline platelet count \<100 × 10⁹/L.
* Chronic liver disease with total bilirubin \>30 μmol/L.
* History of stroke or cerebral hemorrhage with a baseline Glasgow Coma Scale score \<10.
* Chronic renal insufficiency with serum creatinine \>110 μmol/L or long-term daily urine output \<500 mL.
* Unable to tolerate electroacupuncture treatment.
* Currently participating in another interventional clinical study.
* Any other condition that, in the investigator's judgment, makes the patient unsuitable for participation.

Where it's running

  • Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
    Hangzhou, Zhejiang, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.